Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease
Marie‐Laure Boof, Jasper Dingemanse, Mareile Brunke, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 4
Closed Access | Times Cited: 19

Showing 19 citing articles:

Daridorexant: First Approval
Anthony Markham
Drugs (2022) Vol. 82, Iss. 5, pp. 601-607
Open Access | Times Cited: 57
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
Dieter Kunz, Yves Dauvilliers, Heike Beneš, et al.
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 93-106
Open Access | Times Cited: 53
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 24
New drugs under development for COPD
Isabel Uwagboe, Ian M. Adcock, Federica Lo Bello, et al.
Minerva Medica (2022) Vol. 113, Iss. 3
Closed Access | Times Cited: 37
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Shahrokh Javaheri, Sogol Javaheri, David Gozal, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 13, pp. 1224-1240
Closed Access | Times Cited: 6
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem
Mike Ufer, Debra Kelsh, Kerri A. Schoedel, et al.
SLEEP (2021) Vol. 45, Iss. 3
Open Access | Times Cited: 31
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Daridorexant for the Treatment of Insomnia
Christopher L. Robinson, Rajesh Supra, Evan Downs, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 15
Daridorexant in Insomnia Disorder: A Profile of Its Use
Tina Nie, Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 267-274
Open Access | Times Cited: 8
Daridorexant for the treatment of insomnia disorder: findings and implications
Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1749-1761
Closed Access | Times Cited: 12
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 2
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
Dwaipayan Sarathi Chakraborty, Shouvik Choudhury, Sandeep Lahiry
Sleep Science (2023) Vol. 16, Iss. 02, pp. 256-264
Open Access | Times Cited: 6
Daridorexant: Comprehensive Review of A New Oral Agent for the Treatment of Insomnia
Juliane Park, Kandon P. Render, Drew W. Cates
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 5
Daridorexant: A New Dual Orexin Receptor Antagonist for Insomnia
Erin St. Onge, Bradley Phillips, Casey Rowe
Journal of Pharmacy Technology (2022) Vol. 38, Iss. 5, pp. 297-303
Open Access | Times Cited: 8
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in the Treatment of Insomnia
Dwaipayan Sarathi Chakraborty, Shouvik Choudhury, Sandeep Lahiry
Current Drug Research Reviews (2022) Vol. 15, Iss. 2, pp. 149-158
Closed Access | Times Cited: 8
Daridorexant, an Orexin Receptor Antagonist for the Management of Insomnia
Jadwiga Najib, Yuliana Toderika, Lorena Dima
American Journal of Therapeutics (2023) Vol. 30, Iss. 4, pp. e360-e368
Closed Access | Times Cited: 4
Comorbidity of Obstructive Sleep Apnea and Narcolepsy: A Challenging Diagnosis and Complex Management
Silvia Miano, David Gozal, Marco De Pieri
Sleep Medicine X (2024) Vol. 8, pp. 100126-100126
Open Access | Times Cited: 1
Effect of Daridorexant on the Pharmacokinetics of P-Glycoprotein Substrate Dabigatran Etexilate and Breast Cancer Resistance Protein Substrate Rosuvastatin in Healthy Subjects
Marion Anliker‐Ort, Jasper Dingemanse, Luboš Janů, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 11, pp. 827-837
Closed Access | Times Cited: 1
Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease
Jocelyn Y. Cheng, Daniel Lorch, Nancy Hall, et al.
Journal of Sleep Research (2024)
Open Access
Page 1

Scroll to top